Danaher Corporation vs PayPal Holdings, Inc. — how do they compare? Danaher Corporation trades at $206.41 (market cap $145.83B), while PayPal Holdings, Inc. trades at $58.45 (market cap $50.47B). The key difference: Danaher Corporation is far larger — about 2.9× PayPal Holdings, Inc.'s market cap, and PayPal Holdings, Inc. pays the higher dividend (0.95%). Which is the better fit depends on your goals.
| DHR | PYPL | |
|---|---|---|
Market Cap | $145.83B | $50.47B |
Sector | Health | Financials |
52-Week High | $242.05 | $76.13 |
52-Week Low | $161.91 | $39.08 |
Enterprise Value | $168.04B | $52.62B |
Dividend Yield | 0.77% | 0.95% |
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $209.26, up 2.2% today, with strong technical momentum as the price sits above key support levels. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.92. Fundamentals show robust profitability with a 58.51% gross margin and 15.95% net income margin, though revenue growth has been modest. Analyst sentiment is overwhelmingly positive with 69% buy ratings and a $202.33 consensus price target. Recent news highlights the acquisition of Masimo and new product launches in its biotechnology segment.
The outlook for DHR remains favorable driven by earnings beats and strategic acquisitions, but investors face risks from elevated valuation multiples and potential macroeconomic headwinds. The stock's current technical overbought condition suggests near-term consolidation may occur, yet long-term growth prospects in life sciences support a bullish stance. Key watch points include Q3 2026 earnings results and integration progress of recent acquisitions.
PayPal (PYPL) trades at $58.43, down 1.08% on the day, with a bullish technical signal from moving averages and a neutral RSI near 69. The stock shows strong fundamentals with a P/E of 11.15, net income margin of 14.36%, and revenue growth to $33.17B in 2025. Recent Q2 2026 earnings beat expectations with EPS of $1.38, and the company raised full-year guidance, signaling a turnaround under new leadership. News highlights include acquisition interest from Stripe and Advent International, rejected as too low, and expanded partnerships like Synchrony's Mastercard financing.
PYPL presents a value opportunity with low valuation multiples and robust cash flow, but faces risks from competitive pressures and economic sensitivity. Analyst consensus is mixed with a $58.75 price target, while institutional activity shows both position increases and cuts. The stock's upside depends on execution of the turnaround plan and sustained transaction volume growth amid macroeconomic uncertainties.
Trailing returns across standard periods
Latest headlines on both assets
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →